Lifestyle
- Increase physical activity
- Reduce stress levels
- Improve sleep quality
Omega-3 Index · EPA+DHA Index · Fatty Acid Status
The Omega-3 Index quantifies the percentage of EPA and DHA in red blood cell membranes.
Ranges apply to both sexes; fasting not required.
The Omega-3 Index (O3I) is a biomarker that measures the percentage of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in the red blood cell (RBC) membranes. This index reflects the long-term intake of omega-3 fatty acids, which are crucial components of cell membranes and play a significant role in anti-inflammatory processes and cardiovascular health. Clinically, a higher Omega-3 Index is associated with reduced risk of coronary heart disease (CHD) and sudden cardiac death, while a lower index is linked to increased mortality and various cognitive impairments. The index is considered optimal between 8-11%, providing the greatest cardioprotective benefits. For athletes, maintaining an optimal Omega-3 Index can enhance cardiovascular health, improve recovery, and prevent injuries. It is also gaining interest in sports medicine as a marker for performance optimization. However, factors such as dietary intake, genetic variations, and metabolic conditions can influence the Omega-3 Index. Researchers recommend standardized testing methods to ensure accurate assessment, and note that fasting is not required for this test.
Klinische Bedeutung
Elevated Omega-3 Index values (>8%) indicate a reduced risk of coronary heart disease and sudden cardiac death. Reduced values (≤4%) are associated with increased mortality risk, cognitive decline, and psychiatric disorders.
Progressively rising values suggest improved cardiovascular and cognitive health. Retest in 6 months to confirm stability.
Progressively falling values may indicate increased cardiovascular risk or dietary insufficiency.
Re-test Interval
6 months if outside optimal range
Note:
Consult a healthcare provider before starting any supplementation, especially if on medication.
Testing Frequency
Annually for general health monitoring, more frequently if adjusting diet or supplementation.
Current research suggests that optimal Omega-3 Index targets remain debated, with varying reference ranges (2-20%) and an ideal range of 8-11% not universally accepted. Researchers have not yet established the influence of dietary confounders on Omega-3 Index levels across diverse populations. Additionally, clinical questions remain unanswered regarding the specific mechanisms by which the Omega-3 Index affects cardiovascular health and cognitive function, particularly in at-risk populations.
2,189
Total Citations
24
Human/RCT
8.3
Avg. Influence
2024
Latest
This study proposed the Omega-3 Index as a new risk factor for coronary heart disease (CHD). Researchers found that higher O3I levels were inversely associated with CHD mortality, with an O3I of over 8% providing the greatest protection. The findings suggest that the Omega-3 Index could serve as a clinically useful biomarker for assessing CHD risk.
von Schacky Clemens · Nutrients · 2021
Researchers examined the relationship between blood levels of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and brain health. They found that lower Omega-3 Index levels were linked to increased risks of mortality, cognitive decline, and psychiatric disorders. The study suggests that measuring the Omega-3 Index could guide future clinical trials and dietary recommendations.
Key findings
Researchers highlighted the clinical significance of the Omega-3 Index in assessing cardiovascular risk. They noted that low levels of EPA and DHA in red blood cells are linked to increased sudden cardiac death risk. The study advocated for the use of O3I in clinical practice for better patient care.
Researchers reviewed the Omega-3 Index as a potential risk marker for coronary heart disease. They found that lower Omega-3 levels correlate with increased risk for sudden cardiac death, fulfilling many criteria for a risk factor. The study emphasized the importance of O3I in cardiovascular health assessments.
Schuchardt Jan Philipp, et al. · Progress in lipid research · 2024
This study updated the global Omega-3 Index (O3I) map, revealing that most countries have low to very low O3I levels. Researchers found notable improvements in countries like the USA and Canada, while others like Iran and India showed particularly poor levels. The study included data from 328 studies with over 342,000 subjects across 48 countries.
Key findings
This study examined the relationship between red blood cell (RBC) fatty acids and the fatty acid composition of major organs in mice. Researchers found that RBCs, heart, muscle, spleen, lung, and adipose tissues showed strong correlations in their omega-3 and omega-6 fatty acid profiles in response to dietary supplementation with EPA and DHA. This suggests that the omega-3 index in RBCs may reflect fatty acid levels in other tissues.
Researchers proposed the Omega-3 Index as a potential risk factor for sudden cardiac death (SCD), noting a steep dependence of SCD risk on O3I levels. The study supports dietary intake of EPA and DHA to reduce SCD incidence and highlights the index's utility in assessing cardiovascular risk.
Researchers investigated the correlation between the Omega-3 Index and EPA+DHA content in gastrointestinal tissues. They found strong correlations between O3I and tissue levels after dietary supplementation in mice, suggesting that the Omega-3 Index is a valid biomarker for assessing dietary EPA+DHA incorporation into GI tissues.
Researchers assessed dietary and whole blood omega-3 levels among collegiate athletes. They found that the omega-3 index was relatively low, with dietary intakes of omega-3 fatty acids below recommended levels. The study suggests that a questionnaire may help identify athletes at risk for low omega-3 status, particularly among females.
5
Total Trials
985
Total Enrolled
Universidad de Granada
800
2025
omega-3 index
University of Iowa
100
2023
Change from baseline of omega-3 index at 16 and 24 weeks
Samuel Fortin
32
2018
Measurement of the Omega-3 index over time to establish the Pharmacokinetic curve and bioavailability at steady state.
Tufts University
2
2015
Omega-3 index
University of Aberdeen
51
2013
Change in the omega-3 index
Research publications about Omega-3-Index over time
9totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer